STOCK TITAN

Veeva Systems Inc - VEEV STOCK NEWS

Welcome to our dedicated news page for Veeva Systems (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Veeva Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Veeva Systems's position in the market.

Rhea-AI Summary
Veeva Systems (NYSE: VEEV) to announce its third-quarter financial results for fiscal 2024 on December 6, 2023, after market close. The company will host a conference call and webcast to discuss the results and will post prepared remarks on its investor relations website. A webcast replay will be available after the live event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
-
Rhea-AI Summary
Veeva MedTech - Growing Regulatory Complexity Driving Need for a Single Source of Regulatory Information
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.92%
Tags
none
-
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) reveals that compliant chat channels increase HCP engagement by over 30%, with rapid response times of less than five minutes. GSK's global product director emphasizes the importance of responsiveness and value-added communication.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.18%
Tags
none
Rhea-AI Summary
Veeva Systems to host virtual Investor Day on November 9, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
conferences
-
Rhea-AI Summary
LEO Pharma partners with Veeva Systems to optimize safety operations and improve collaboration with affiliates. Veeva Vault Safety provides real-time visibility into adverse events and data transparency. Standardizing drug development on Veeva Development Cloud connects safety to other crucial business areas.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
none
-
Rhea-AI Summary
Veeva Systems announces Veeva Vault Batch Release, a new cloud application for faster GMP release and market-ship decisions. It streamlines data aggregation, reviews, and collaboration, improving efficiency and speed to market. Planned availability in the second half of 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
none
Rhea-AI Summary
Veeva Systems announces Veeva Study Portal and VeevaID to simplify research site access to sponsor technologies
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
none
-
Rhea-AI Summary
Veeva Systems to present at Citi 2023 Global Technology Conference on September 6, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.77%
Tags
conferences
-
Rhea-AI Summary
Veeva Systems has launched Veeva Clinical Database (CDB), a next-generation clinical data application that saves customers 30 to 50% of the time required to aggregate, clean, and transform data. Veeva CDB has already cleaned more than 200,000 subjects across more than 200 studies. The application automates processes for data cleaning, change detection, and collaboration, increasing productivity and efficiency. Veeva CDB is part of Veeva Vault Clinical Data Management Suite.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.36%
Tags
Rhea-AI Summary
Veeva Systems Inc. reports Q2 2023 revenues of $590.2M, up 10% YoY. Subscription services revenues also increase by 10% YoY to $470.6M. Net income increases by 23% YoY to $111.6M. Positive financial performance ahead of guided metrics. Fiscal 2024 Q3 revenue guidance of $614-616M. Fiscal 2024 revenue guidance of $2,365-2,370M. Fiscal 2025 revenue guidance of at least $2,800M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.36%
Tags
Veeva Systems Inc

NYSE:VEEV

VEEV Rankings

VEEV Stock Data

33.35B
147.86M
8.2%
84.17%
1.48%
Software Publishers
Information
Link
United States
Pleasanton

About VEEV

veeva systems inc. is a leader in cloud-based software for the global life sciences industry. committed to innovation, product excellence, and customer success, veeva has more than 300 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. veeva is headquartered in the san francisco bay area, with offices in europe, asia, and latin america. for more information, visit www.veeva.com.